Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
FDA grants orphan drug designation to gene therapy for ALS
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
Arcus Biosciences receives Orphan Drug Designation for pancreatic cancer treatment
IGI and AbbVie announce exclusive global licensing agreement for trispecific antibody
Angelman syndrome results published
Champions Oncology launches radiopharmaceutical services platform
Partnership created scale up cell-based mRNA design and manufacturing platform
New drug target for treating cancer and viral infections